118 related articles for article (PubMed ID: 7784812)
1. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever.
Engervall P; Granström M; Andersson B; Björkholm M
Eur J Haematol; 1995 Apr; 54(4):226-34. PubMed ID: 7789467
[TBL] [Abstract][Full Text] [Related]
4. Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.
Guidet B; Piot O; Masliah J; Barakett V; Maury E; Bereziat G; Offenstadt G
Infection; 1996; 24(2):103-8. PubMed ID: 8740100
[TBL] [Abstract][Full Text] [Related]
5. Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections.
Rintala EM; Nevalainen TJ
Clin Infect Dis; 1993 Nov; 17(5):864-70. PubMed ID: 8286627
[TBL] [Abstract][Full Text] [Related]
6. Membrane-associated phospholipase A2 detected by a radioimmunoassay is a sensitive marker of inflammation in rheumatoid arthritis.
Sakamoto K; Arakawa H; Yamashita S; Mizuta H; Takaki K; Ogawa M
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):279-85. PubMed ID: 1636052
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
8. Serum phospholipase A2 in patients with multiple organ failure.
Nyman KM; Uhl W; Forsström J; Büchler M; Beger HG; Nevalainen TJ
J Surg Res; 1996 Jan; 60(1):7-14. PubMed ID: 8592435
[TBL] [Abstract][Full Text] [Related]
9. Postoperative elevations of serum interleukin 6 and group II phospholipase A2: group II phospholipase A2 in serum is an acute phase reactant.
Ogawa M; Arakawa H; Yamashita S; Sakamoto K; Ikei S
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):109-15. PubMed ID: 1626121
[TBL] [Abstract][Full Text] [Related]
10. Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy.
Rintala EM; Nevalainen TJ
Eur J Haematol; 1993 Jan; 50(1):11-6. PubMed ID: 8436209
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical detection of group I and group II phospholipases A2 in human serum.
Nevalainen TJ; Kortesuo PT; Rintala E; Märki F
Clin Chem; 1992 Sep; 38(9):1824-9. PubMed ID: 1526020
[TBL] [Abstract][Full Text] [Related]
12. Blood cytokine and complement levels in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Kikuchi M; Baba N; Inada K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):291-300. PubMed ID: 7938903
[TBL] [Abstract][Full Text] [Related]
13. Endotoxaemia and inflammatory mediators in febrile patients with haematological disease.
Günther G; Gårdlund B; Hast R; Kimby E; Nordin M; Wretlind B
J Intern Med; 1995 Jan; 237(1):27-33. PubMed ID: 7830027
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of C-reactive protein, interleukin-6 and -10, and phospholipase A2-II in severely traumatized septic patients.
Lausević Z; Vuković G; Stojimirović B; Trbojević-Stanković J; Resanović V; Lausevic M
Vojnosanit Pregl; 2010 Nov; 67(11):893-7. PubMed ID: 21268514
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome.
Rintala E; Peuravuori H; Pulkki K; Voipio-Pulkki LM; Nevalainen T
Intensive Care Med; 2000 Sep; 26(9):1248-51. PubMed ID: 11089749
[TBL] [Abstract][Full Text] [Related]
16. Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia.
Pruzanski W; Mackensen A; Engelhardt R; Stefanski E; Vadas P
J Immunother (1991); 1992 Nov; 12(4):242-6. PubMed ID: 1477075
[TBL] [Abstract][Full Text] [Related]
17. A multicenter study of phospholipase A2 in patients in intensive care units.
Uhl W; Beger HG; Hoffmann G; Hanisch E; Schild A; Waydhas C; Entholzner E; Müller K; Kellermann W; Vogeser M
J Am Coll Surg; 1995 Mar; 180(3):323-31. PubMed ID: 7874343
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 is a circulating mediator in typhoid fever.
Keuter M; Dharmana E; Kullberg BJ; Schalkwijk C; Gasem MH; Seuren L; Djokomoeljanto R; Dolmans WM; van den Bosch H; van der Meer JW
J Infect Dis; 1995 Jul; 172(1):305-8. PubMed ID: 7797937
[TBL] [Abstract][Full Text] [Related]
19. Value of measurement of C-reactive protein in febrile patients with hematological malignancies.
Rintala E; Irjala K; Nikoskelainen J
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):973-8. PubMed ID: 1295765
[TBL] [Abstract][Full Text] [Related]
20. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
